NCT07491861 Mindfulness-Based Stress Reduction for Emotional Recovery After Stroke
| NCT ID | NCT07491861 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HealthPartners Institute |
| Condition | Chronic Stroke Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-04 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-04 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot study is to examine the feasibility, acceptability, and preliminary effects of mindfulness-based stress reduction (MBSR) on interoception (your understanding of your body's internal senses), emotional well-being, and whole person health. A total of 30 people with chronic stroke will be enrolled in this study to participate in an MBSR course, consisting of a 30-minute intake visit, 8 sessions lasting 2.5 hours plus a 1-day 7-hour retreat. Participants will be randomized into either the first MBSR course (immediate start) or the second MBSR course (delayed start/waitlist control).
Eligibility Criteria
Inclusion Criteria: * Ability to consent to study participation * Age 18+ * Diagnosis of stroke ≥6 months prior to enrollment * A score of 5 or more on the Kessler Psychological Distress Scale (K6) * Reliable and consistent internet access and a device with video conferencing (e.g. Zoom) capabilities (e.g., smart phone, tablet, or laptop/computer) for the duration of the study * Able to attend an 8-week mindfulness course on Friday afternoons, starting approximately in mid-May or mid-July Exclusion Criteria: * Non-English speaking * Prior completion of an MBSR course * Active participation or past participation ≤3 months in any other interventional research study * History of any serious/uncontrolled neurological, psychiatric, or substance use disorder that would impact study participation * Any other clinically relevant finding that would pose a safety risk to the subject as determined by the investigator
Contact & Investigator
Amanda Herrmann, PhD
PRINCIPAL INVESTIGATOR
HealthPartners Institute
Frequently Asked Questions
Who can join the NCT07491861 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Stroke Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07491861 currently recruiting?
Yes, NCT07491861 is actively recruiting participants. Contact the research team at Meghan.E.Obrien@HealthPartners.com for enrollment information.
Where is the NCT07491861 trial being conducted?
This trial is being conducted at Saint Paul, United States.
Who is sponsoring the NCT07491861 clinical trial?
NCT07491861 is sponsored by HealthPartners Institute. The principal investigator is Amanda Herrmann, PhD at HealthPartners Institute. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.